|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| A61P 27/02 |
| (11) | Number of the document | 2510098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10809113.3 |
| Date of filing the European patent application | 2010-12-09 | |
| (97) | Date of publication of the European application | 2012-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2015-02-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/059597 |
| Date | 2010-12-09 |
| (87) | Number | WO 2011/072091 |
| Date | 2011-06-16 |
| (30) | Number | Date | Country code |
| 267835 P | 2009-12-09 | US | |
| 319894 P | 2010-04-01 | US |
| (72) |
FEINSTEIN, Elena, IL
SPIVAK, Igor, IL
ALPERT, Evgenia, IL
LAHAV, Ron, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (54) | METHODS AND COMPOSITIONS FOR TREATING DISEASES, DISORDERS OR INJURY OF THE CNS |
| METHODS AND COMPOSITIONS FOR TREATING DISEASES, DISORDERS OR INJURY OF THE CNS |